Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells

Abstract

Unlike autosomal tumor suppressors, X-linked tumor suppressors can be inactivated by a single hit due to X-chromosome inactivation (XCI). Here, we argue that targeted reactivation of the non-mutated allele from XCI offers a potential therapy for female breast cancers.

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 07, 2022
Source ID
10.1186/s12943-021-01472-x

Entities

People

  • Chao Zhang
  • Dehua Zhao
  • Erica Stringer-reasor
  • Lei S Qi
  • Leiping Zeng
  • Lizhong Wang
  • Runhua Liu
  • Sejong Bae
  • Shuaibin Wang
  • Xin Li
  • Xuelian Cui
  • Zhifang Xu

Organizations

  • Congressionally Directed Medical Research Programs
  • The Breast Cancer Research Foundation

Tags

Fields of Study

  • Biology

Readers

  • Molecular Biology and Genetics
  • Oncology
  • Prostate Cancer Biology.

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech